In AT1a-null mice, AII may act via AT2 receptors activating PPAR-γ and contribute to inhibition of inflammation and oxidative stress, which has been observed to promote longevity and inhibit progression of degenerative diseases in AT1-null mice [58-60]. This evidence concerns the gene AGTR1 and neurodegenerative disease.